Despite the silence that stigma often brings, the joy and power of Black people living with HIV are loud when you know where ...

Recently, the Wall Street Journal reported that the Trump administration is considering eliminating all CDC domestic HIV ...

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 — but only if between two and four million HIV-negative people in the country would need to use the jab ...

Women may experience unique symptoms of HIV. Early on, human immunodeficiency virus (HIV) typically causes flu-like symptoms, which are similar across sexes. HIV symptoms in women may differ after ...

Human immunodeficiency virus, if untreated, causes acquired immunodeficiency syndrome (AIDS), and death. HIV is almost entirely preventable by using condoms, or by taking PrEP drugs. PrEP drugs do not ...

The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be ...

A new report from GlobalData has raised concerns over the effectiveness of mpox vaccines for people living with HIV. Findings ...

Is long-acting HIV treatment as effective as daily pills? Early results say yes—with some risks of resistance in rare cases.

A modelling study shows that lenacapavir could end Aids in South Africa by 2032 – but only if between two and four million HIV-negative people in the country use the jab every year over the next eight ...

"In these patients, the sensitivity of standard tests is much lower than in the HIV-negative population. However, in patients with advanced AIDS, our results show that stool molecular detection is ...